87 related articles for article (PubMed ID: 24813742)
1. Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.
Tauro M; Loiodice F; Ceruso M; Supuran CT; Tortorella P
Bioorg Med Chem Lett; 2014 Jun; 24(12):2617-20. PubMed ID: 24813742
[TBL] [Abstract][Full Text] [Related]
2. Arylamino bisphosphonates: potent and selective inhibitors of the tumor-associated carbonic anhydrase XII.
Tauro M; Loiodice F; Ceruso M; Supuran CT; Tortorella P
Bioorg Med Chem Lett; 2014 Apr; 24(8):1941-3. PubMed ID: 24650641
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II.
Carta F; Maresca A; Scozzafava A; Vullo D; Supuran CT
Bioorg Med Chem; 2009 Oct; 17(20):7093-9. PubMed ID: 19773173
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
[TBL] [Abstract][Full Text] [Related]
8. Membrane-bound carbonic anhydrases in osteoclasts.
Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII.
Grandane A; Tanc M; Zalubovskis R; Supuran CT
Bioorg Med Chem; 2014 Mar; 22(5):1522-8. PubMed ID: 24513186
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
13. Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids.
Luisi G; Angelini G; Gasbarri C; Laghezza A; Agamennone M; Loiodice F; Supuran CT; Campestre C; Tortorella P
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1260-1264. PubMed ID: 28948845
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties.
Ceruso M; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem; 2013 Nov; 21(22):6929-36. PubMed ID: 24103430
[TBL] [Abstract][Full Text] [Related]
16. Attachment of carbohydrates to methoxyaryl moieties leads to highly selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Riafrecha LE; Rodríguez OM; Vullo D; Supuran CT; Colinas PA
Bioorg Med Chem; 2014 Oct; 22(19):5308-14. PubMed ID: 25156300
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.
Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem; 2008 Aug; 16(15):7424-8. PubMed ID: 18579385
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors.
Saczewski F; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Sep; 16(18):4846-51. PubMed ID: 16809036
[TBL] [Abstract][Full Text] [Related]
19. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
20. New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.
Carta F; Vullo D; Maresca A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2012 Mar; 22(6):2182-5. PubMed ID: 22365761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
